[go: up one dir, main page]

NO972849L - Peptid p277 analoger og farmasöytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes - Google Patents

Peptid p277 analoger og farmasöytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes

Info

Publication number
NO972849L
NO972849L NO972849A NO972849A NO972849L NO 972849 L NO972849 L NO 972849L NO 972849 A NO972849 A NO 972849A NO 972849 A NO972849 A NO 972849A NO 972849 L NO972849 L NO 972849L
Authority
NO
Norway
Prior art keywords
analogs
diabetes
peptide
diagnosis
treatment
Prior art date
Application number
NO972849A
Other languages
English (en)
Other versions
NO317350B1 (no
NO972849D0 (no
Inventor
Irun R Cohen
Dana Elias
Matityahu Fridkin
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26322965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO972849(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL11209494A external-priority patent/IL112094A0/xx
Priority claimed from IL11446095A external-priority patent/IL114460A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO972849D0 publication Critical patent/NO972849D0/no
Publication of NO972849L publication Critical patent/NO972849L/no
Publication of NO317350B1 publication Critical patent/NO317350B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19972849A 1994-12-21 1997-06-19 Peptid p277 analoger og farmasoytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes NO317350B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11209494A IL112094A0 (en) 1994-12-21 1994-12-21 Novel peptides and pharmaceutical compositions comprising them
IL11446095A IL114460A0 (en) 1995-07-05 1995-07-05 Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
PCT/US1995/016596 WO1996019236A1 (en) 1994-12-21 1995-12-20 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES

Publications (3)

Publication Number Publication Date
NO972849D0 NO972849D0 (no) 1997-06-19
NO972849L true NO972849L (no) 1997-08-13
NO317350B1 NO317350B1 (no) 2004-10-18

Family

ID=26322965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972849A NO317350B1 (no) 1994-12-21 1997-06-19 Peptid p277 analoger og farmasoytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes

Country Status (31)

Country Link
EP (1) EP0820303B1 (no)
JP (2) JP3420245B2 (no)
KR (1) KR100400480B1 (no)
CN (1) CN1233417C (no)
AR (1) AR002949A1 (no)
AT (1) ATE242005T1 (no)
AU (1) AU707835B2 (no)
BR (1) BR9510102A (no)
CA (1) CA2208274C (no)
CZ (1) CZ293784B6 (no)
DE (2) DE820303T1 (no)
DK (1) DK0820303T3 (no)
ES (1) ES2201137T3 (no)
FI (1) FI118373B (no)
HR (1) HRP950612B1 (no)
HU (1) HU224160B1 (no)
IL (1) IL116499A0 (no)
IS (1) IS1966B (no)
MX (1) MX9704738A (no)
NO (1) NO317350B1 (no)
NZ (1) NZ301440A (no)
PL (1) PL184145B1 (no)
PT (1) PT820303E (no)
RO (1) RO116777B1 (no)
RS (1) RS49517B (no)
SI (1) SI0820303T1 (no)
TR (1) TR199501630A2 (no)
TW (1) TW496872B (no)
UA (1) UA42040C2 (no)
UY (1) UY24130A1 (no)
WO (1) WO1996019236A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6488933B2 (en) 1995-07-05 2002-12-03 Yeda Research And Development Co. Ltd. Preparations for the treatment of T cell mediated diseases
DE69724619T2 (de) * 1996-05-14 2004-07-01 Winnacker, Ernst-Ludwig, Prof. Chaperone, die prionproteine binden und zwischen den isoformen prpc und prpsc unterscheiden können
WO2002016549A2 (en) * 2000-08-25 2002-02-28 Yeda Research And Development Co. Ltd. METHODS OF TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH CpG-CONTAINING POLYNUCLEOTIDE
IL140233A0 (en) * 2000-12-11 2002-02-10 Peptor Ltd Backbone cyclized analogs of heat shock proteins
WO2003063759A2 (en) 2002-01-31 2003-08-07 Peptor Ltd. Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
AU2005207891B2 (en) 2004-01-28 2010-04-01 Andromeda Biotech Ltd. Hsp therapy in conjunction with a low antigenicity diet
DE102004043750A1 (de) * 2004-09-10 2006-03-30 Sanofi-Aventis Deutschland Gmbh Formulierungen des Peptids p277 oder dessen Varianten mit optimierter Stabilität
CN100352502C (zh) * 2004-12-29 2007-12-05 中国药科大学 能通过免疫防治ⅰ型糖尿病的重组蛋白和重组基因
WO2006072946A2 (en) 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US8211430B2 (en) 2005-03-04 2012-07-03 Curedm Group Holdings, Llc Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
CA2726759C (en) 2005-05-25 2016-02-16 Curedm Group Holdings, Llc Human proislet peptide, derivatives and analogs thereof, and methods of using same
JP4283812B2 (ja) * 2006-01-06 2009-06-24 財団法人工業技術研究院 重症筋無力症の診断方法およびそのキット
US8785400B2 (en) 2006-11-22 2014-07-22 Curedm Group Holdings, Llc Methods and compositions relating to islet cell neogenesis
CA2698100C (en) 2007-08-30 2017-06-06 Curedm, Inc. Compositions and methods of using proislet peptides and analogs thereof
CU23701A1 (es) * 2008-12-29 2011-09-21 Ct Ingenieria Genetica Biotech Método de tratamiento de enfermedades inflamatorias intestinales y diabetes tipo i
WO2013128450A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Hsp60 derived peptides and peptide analogs for suppression and treatment of non-autoimmune diabetes
WO2013128453A1 (en) 2012-03-01 2013-09-06 Yeda Research And Development Co. Ltd. Regeneration of islet beta cells by hsp60 derived peptides
CN104418948B (zh) * 2013-09-10 2019-08-16 深圳翰宇药业股份有限公司 一种制备多肽药物的方法
CN104650209B (zh) * 2013-11-19 2018-04-06 深圳翰宇药业股份有限公司 多肽药物DiaPep277 的合成方法
CN104650244B (zh) * 2015-01-21 2017-12-08 中国药科大学 一种具有降血糖兼调脂作用的表位组合肽及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus

Also Published As

Publication number Publication date
NO317350B1 (no) 2004-10-18
DE69531004D1 (de) 2003-07-10
CA2208274C (en) 2005-12-06
WO1996019236A1 (en) 1996-06-27
EP0820303A4 (no) 1998-03-11
AU707835B2 (en) 1999-07-22
SI0820303T1 (en) 2003-10-31
IS4510A (is) 1997-06-19
CN1175214A (zh) 1998-03-04
JP3554319B2 (ja) 2004-08-18
HU224160B1 (hu) 2005-06-28
EP0820303A1 (en) 1998-01-28
JPH10511649A (ja) 1998-11-10
HUT78092A (hu) 1999-09-28
DE820303T1 (de) 1999-05-20
RS49517B (sr) 2006-10-27
YU78795A (sh) 1998-05-15
TW496872B (en) 2002-08-01
HRP950612A2 (en) 1997-10-31
BR9510102A (pt) 1997-11-25
ES2201137T3 (es) 2004-03-16
FI972669A0 (fi) 1997-06-19
PL321091A1 (en) 1997-11-24
CZ190897A3 (en) 1997-11-12
KR100400480B1 (ko) 2003-12-31
FI972669A (fi) 1997-08-15
JP2004026797A (ja) 2004-01-29
IS1966B (is) 2004-12-15
UA42040C2 (uk) 2001-10-15
RO116777B1 (ro) 2001-06-29
CN1233417C (zh) 2005-12-28
AR002949A1 (es) 1998-05-27
AU4686696A (en) 1996-07-10
ATE242005T1 (de) 2003-06-15
PT820303E (pt) 2003-10-31
PL184145B1 (pl) 2002-09-30
FI118373B (fi) 2007-10-31
CZ293784B6 (cs) 2004-07-14
DK0820303T3 (da) 2003-10-06
HRP950612B1 (en) 2003-12-31
IL116499A0 (en) 1996-03-31
JP3420245B2 (ja) 2003-06-23
CA2208274A1 (en) 1996-06-27
DE69531004T2 (de) 2004-02-05
MX9704738A (es) 1997-10-31
NZ301440A (en) 2000-01-28
UY24130A1 (es) 1996-06-11
TR199501630A2 (tr) 1996-07-21
EP0820303B1 (en) 2003-06-04
NO972849D0 (no) 1997-06-19

Similar Documents

Publication Publication Date Title
NO972849L (no) Peptid p277 analoger og farmasöytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes
EE200000380A (et) 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
CA2180950A1 (en) Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
NO991130L (no) Modifiserte aminosyrer, farmas°ytiske preparater som inneholder disse forbindelsene og fremgangsmÕter for fremstilling derav
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
BR9502797A (pt) Complexos de análogo de insulina-protamina suas formulações farmaceuticas parenterais processos para preparação dos ditos análogos e das formulações farmacêuticas e cristais de insulina-protamina
DE69832298D1 (de) Gerät zur kontrollierten abgabe von pharmazeutischen und medizinischen produkten
DE69820108D1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
NZ263344A (en) Human bactericidal/permeability increasing (bpi) protein functional domain peptides and their use
DK0725097T3 (da) Anvendelse af humant atrialt natriuretisk peptid til fremstilling af farmaceutiske præparater til behandling af akut lungeb
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
EE9400326A (et) Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
NO983465L (no) Farmasöytisk kombinasjonspreparater inneholdende LHRH-analoger og antiöstrogener for behandling av gynekologiske forstyrrelser
DK1222921T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og/eller nitazoxanid
NO953003D0 (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
ZA9510828B (en) Peptide p277 analogs and phamarceutical compositions comprising them for treatment or diagnosis of diabetes
NO960664L (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåter for deres fremstilling, deres anvendelse for fremstilling av farmasöytiske preparater og medikamenter inneholdende disse
BR9611619B1 (pt) ciclopeptolìdeos e composição farmacêutica que os contêm.
IL114460A0 (en) Peptide p277 analogs and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
DK575287A (da) Anvendelse af vaevsfaktorprotein og antagonister herfor til fremstilling af laegemidler til behandling af bloedningsforstyrrelser samt farmaceutiske praeparater indeholdende disse
ITMI921861A0 (it) Procedimento per la preparazione di (-) eseretolo da miscele di (-) e (+)- eseterolo
NO920620L (no) Polypeptidanaloger av apolipoprotein e, diagnostiske systemer og fremgangsmaater ved anvendelse av analogene

Legal Events

Date Code Title Description
MK1K Patent expired